Medical Oncology

Prof. Dr. Halil Taşkaynatan

Doctor and researcher İzmir Şehir Hastanesi İzmir
Breast NeoplasmsPancreatic NeoplasmsNeoplasmsStomach NeoplasmsColorectal NeoplasmsLung NeoplasmsCarcinoma, Ovarian EpithelialNeoplasms, Glandular and Epithelial

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 8 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Pancreatic Neoplasms 3 publications
  • Neoplasms 3 publications
  • Stomach Neoplasms 2 publications
  • Colorectal Neoplasms 2 publications
  • Lung Neoplasms 2 publications
  • Carcinoma, Ovarian Epithelial 2 publications
  • Neoplasms, Glandular and Epithelial 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologysaglik.gov.trFrom source
  • Institutionİzmir Şehir Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 8 publications · Model version —From source
  • Publications62 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0002-3671-6540ORCIDFrom source
  • Last synchronised5 November 2026 09:07https://izmirsehir.saglik.gov.tr/TR-1046789/doktorlarimiz.html#halil-taskaynatansaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

62 publications
  1. Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15103979 PMID 42194940 Open-access full textSource: OpenAlex

  2. The RATAB Framework: An Interpretable AI-Driven Radiographic Risk Stratification Model for Suspected Lung Lesions

    Journal of Imaging Informatics in Medicine, 2026

    DOI 10.1007/s10278-026-02303-5 PMID 42768277 Source: OpenAlex

  3. KIM-1 immunohistochemistry and early ccRCC recurrence outside adjuvant eligibility criteria: a two-centre exploratory study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-17191-9 Open-access full textSource: OpenAlex

  4. Prevalence and impact of germline mutations in pancreatic ductal adenocarcinoma

    Tumori Journal, 2026

    DOI 10.1177/03008916251410475 PMID 41568754 Source: ORCID

  5. Immunoscore and Post-Neoadjuvant Pathological Features in Microsatellite-Stable Locally Advanced Gastric Cancer: A Retrospective Cohort Study

    Cancers, 2026

    DOI 10.3390/cancers18203329 PMID 42938863 Open-access full textSource: ORCID

  6. Pretreatment Claudin-18.2 Expression Predicts Poorer Survival Outcomes in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy

    Diagnostics, 2026

    DOI 10.3390/diagnostics16091277 PMID 42121981 Open-access full textSource: ORCID

  7. Association of Abdominal Aortic Calcification with Pathological Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Retrospective Exploratory Study

    Asian Pacific journal of cancer prevention : APJCP, 2026

    DOI 10.31557/apjcp.2026.27.10.3723 PMID 42935064 Open-access full textSource: Europe PMC

  8. Leveraging the non-contrast CT component of PET/CT: an AI-driven delta-radiomics approach to monitor treatment response in metastatic breast cancer

    BMC Medical Imaging, 2026

    DOI 10.1186/s12880-026-02463-4 PMID 42185986 Open-access full textSource: OpenAlex

  9. Pretreatment Hemoglobin, Albumin, Lymphocyte, and Platelet Score Predicts Pathological Response and Postoperative Pathological Findings in Locally Advanced Gastric Cancer

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-5-2 Open-access full textSource: OpenAlex

  10. Cumulative chemotherapy exposure and social isolation as correlates of caregiver burden and anxiety among family caregivers in outpatient oncology: a cross-sectional study

    Research Square, 2026

    DOI 10.21203/rs.3.rs-11062964/v1 Open-access full textSource: OpenAlex

View all 62 publications